Infection Augments Expression of Mechanosensing Piezo1 Channels in Amyloid Plaque-Reactive Astrocytes by Velasco-Estevez, Maria et al.
fnagi-10-00332 October 17, 2018 Time: 13:57 # 1
ORIGINAL RESEARCH
published: 22 October 2018
doi: 10.3389/fnagi.2018.00332
Edited by:
Alberto Javier Ramos,
Consejo Nacional de Investigaciones
Científicas y Técnicas (CONICET),
Argentina
Reviewed by:
Jingwen Niu,
Temple University, United States
Vladimir Parpura,
The University of Alabama
at Birmingham, United States
*Correspondence:
Emad Moeendarbary
e.moeendarbary@ucl.ac.uk
Kumlesh K. Dev
devk@tcd.ie
Graham K. Sheridan
G.Sheridan@brighton.ac.uk
Received: 19 June 2018
Accepted: 01 October 2018
Published: 22 October 2018
Citation:
Velasco-Estevez M, Mampay M,
Boutin H, Chaney A, Warn P, Sharp A,
Burgess E, Moeendarbary E, Dev KK
and Sheridan GK (2018) Infection
Augments Expression
of Mechanosensing Piezo1 Channels
in Amyloid Plaque-Reactive
Astrocytes.
Front. Aging Neurosci. 10:332.
doi: 10.3389/fnagi.2018.00332
Infection Augments Expression of
Mechanosensing Piezo1 Channels in
Amyloid Plaque-Reactive Astrocytes
María Velasco-Estevez1,2, Myrthe Mampay1, Hervé Boutin3, Aisling Chaney3,4,
Peter Warn5, Andrew Sharp5, Ellie Burgess5, Emad Moeendarbary6,7* , Kumlesh K. Dev2*
and Graham K. Sheridan1*
1 Neuroimmulology & Neurotherapeutics Laboratory, School of Pharmacy and Biomolecular Sciences, University of Brighton,
Brighton, United Kingdom, 2 Drug Development, Department of Physiology, School of Medicine, Trinity College Dublin,
Dublin, Ireland, 3 Wolfson Molecular Imaging Centre, Faculty of Biology, Medicine and Health and Manchester Academic
Health Sciences Centre, The University of Manchester, Manchester, United Kingdom, 4 Department of Radiology, Stanford
University, Stanford, CA, United States, 5 Evotec (UK) Ltd., Manchester Science Park, Manchester, United Kingdom,
6 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States, 7 Department
of Mechanical Engineering, University College London, London, United Kingdom
A defining pathophysiological hallmark of Alzheimer’s disease (AD) is the amyloid plaque;
an extracellular deposit of aggregated fibrillar Aβ1−42 peptides. Amyloid plaques are
hard, brittle structures scattered throughout the hippocampus and cerebral cortex
and are thought to cause hyperphosphorylation of tau, neurofibrillary tangles, and
progressive neurodegeneration. Reactive astrocytes and microglia envelop the exterior
of amyloid plaques and infiltrate their inner core. Glia are highly mechanosensitive cells
and can almost certainly sense the mismatch between the normally soft mechanical
environment of the brain and very stiff amyloid plaques via mechanosensing ion
channels. Piezo1, a non-selective cation channel, can translate extracellular mechanical
forces to intracellular molecular signaling cascades through a process known as
mechanotransduction. Here, we utilized an aging transgenic rat model of AD (TgF344-
AD) to study expression of mechanosensing Piezo1 ion channels in amyloid plaque-
reactive astrocytes. We found that Piezo1 is upregulated with age in the hippocampus
and cortex of 18-month old wild-type rats. However, more striking increases in Piezo1
were measured in the hippocampus of TgF344-AD rats compared to age-matched
wild-type controls. Interestingly, repeated urinary tract infections with Escherichia coli
bacteria, a common comorbidity in elderly people with dementia, caused further
elevations in Piezo1 channel expression in the hippocampus and cortex of TgF344-
AD rats. Taken together, we report that aging and peripheral infection augment amyloid
plaque-induced upregulation of mechanoresponsive ion channels, such as Piezo1, in
astrocytes. Further research is required to investigate the role of astrocytic Piezo1 in the
Alzheimer’s brain, whether modulating channel opening will protect or exacerbate the
disease state, and most importantly, if Piezo1 could prove to be a novel drug target for
age-related dementia.
Keywords: Alzheimer’s disease, amyloid plaques, astrocytes, dentate gyrus, mechanosensitive ion channel,
Piezo1, TgF344-AD rats, urinary tract infection
Frontiers in Aging Neuroscience | www.frontiersin.org 1 October 2018 | Volume 10 | Article 332
fnagi-10-00332 October 17, 2018 Time: 13:57 # 2
Velasco-Estevez et al. Astrocytic Piezo1 and Alzheimer’s Disease
INTRODUCTION
The etiology of early-onset Alzheimer’s disease (AD) has a strong
genetic component and mutations in genes that encode for
amyloid precursor protein (APP), presenilin 1 (PSEN1), and
presenilin 2 (PSEN2) give rise to a rare but severe form of familial
dementia characterized by cortical and hippocampal atrophy and
progressive cognitive decline (Saunders, 2001; Nacmias et al.,
2014; Lanoiselee et al., 2017). The amyloid cascade hypothesis
of AD (Hardy and Allsop, 1991) states that aberrant cleavage
of APP by γ-secretase results in the accumulation of cytotoxic
oligomeric amyloid-β1−42 (Aβ1−42) which aggregates and forms
β-sheet fibrillar structures that, in turn, clump together and
generate extracellular amyloid plaques (Lukiw, 2012; Morris et al.,
2014). Amyloid plaques contribute to cortical and hippocampal
neurodegeneration and neuroinflammation (Nobakht et al.,
2011; Dansokho and Heneka, 2018), although extensive plaque
pathology is not necessarily a good indicator of the clinical
severity of dementia (Hyman et al., 1993). Structurally, amyloid
plaques are very brittle and stiff (with a stiffness of ∼3 × 109 Pa)
(Smith et al., 2006), in contrast to brain tissue which we have
previously shown to be very soft (with a stiffness of ∼200–
500 Pa) (Moeendarbary et al., 2017). Therefore, neurons and glia
surrounding the amyloid plaque experience a large perturbation
to their mechanical microenvironment. Astrocytes, the most
abundant glial cell type in the brain, respond to amyloid plaque
accumulation by adopting a ‘reactive’ phenotype characterized
by an increase in intermediate filament expression, e.g., GFAP
(Wilhelmsson et al., 2006; Sofroniew, 2009), and synthesis
of proinflammatory cytokines (Buffo et al., 2010; Sofroniew,
2014). We hypothesize that, in addition to biochemical signals,
astrogliosis in the AD brain is triggered in part by a detectable
increase in the stiffness of the mechanical microenvironment
experienced by resting glial cells.
Neurons and glia are highly mechanosensitive (Previtera
et al., 2010; Blumenthal et al., 2014) and detect changes in
the stiffness of underlying cell culture substrates via stretch-
activated membrane-spanning ion channels (Cox et al., 2016;
Bavi et al., 2017). Microglial cells, for example, display durotaxis,
i.e., they migrate toward stiffer areas when cultured on stiffness
gradient hydrogels (Bollmann et al., 2015). Astrocytes grown
on stiff hydrogels possess longer, thicker processes and appear
much more reactive than those cultured on soft hydrogels
(Moshayedi et al., 2010). Moreover, astrocytes in vivo respond
to hard foreign body implants by releasing proinflammatory
cytokines, such as Il-1β (Moshayedi et al., 2014). In AD, the
build-up of extracellular amyloid plaques causes astrogliosis and,
given the stiffness of plaques, we hypothesize that astrocyte
reactivity is mediated partly by activation of mechanosensitive
Abbreviations: Aβ42, amyloid-β 1–42 peptide; BSA, bovine serum albumin;
CMM, conditioned microglial media; CNS, central nervous system; DMEM,
Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; GFAP, glial
fibrillary acidic protein; HBSS, Hank’s buffered salt solution; HRP, horse radish
peroxidase; iTG, transgenic with infection; iWT, wild-type with infection; NaCl,
sodium chloride; NFH, neurofilament H; PBS, phosphate-buffered saline; PVDF,
polyvinylidene difluoride membrane; SDS, sodium dodecylsulfate; TG, transgenic;
TNF-α, tumor necrosis factor-alpha; WT, wild-type.
ion channels. Therefore, our aim here was to investigate
cellular expression of mechanosensitive Piezo1 channels in
response to amyloid plaque pathology in an aging rat model
of AD.
To carry out this aim, we utilized the TgF344-AD rat
model (Cohen et al., 2013) that overexpress human APP with
the Swedish mutation (APPSWE) and mutated human PSEN1
(PSEN11E9). In the healthy human brain, Piezo1 mRNA is
expressed by neurons but is absent from astrocytes. Post-mortem
analysis of AD brains, however, revealed that Piezo1 mRNA
is down-regulated in neurons and up-regulated in astrocytes
surrounding amyloid plaques (Satoh et al., 2006). Therefore,
Piezo1 was previously known as Mib (membrane protein induced
by beta-amyloid treatment). Piezo1 is a large protein (>2,500
amino acids) predicted to contain 30–40 putative transmembrane
segments (Kamajaya et al., 2014), assembles as a ∼900 kDa
homotrimer (Ge et al., 2015) and forms a non-selective calcium
(Ca2+)-permeable cation channel (Gnanasambandam et al.,
2015). Mechanosensitive ion channels translate external physical
stimuli, such as shear stress (Ranade et al., 2014), pressure
(Gottlieb and Sachs, 2012; Bae et al., 2015) and extracellular
matrix (ECM)-associated traction forces (Pathak et al., 2014) to
intracellular biochemical signals via mechanotransduction events
(Martinac, 2004; Moeendarbary and Harris, 2014). Piezo1 mRNA
is highly expressed in tissues subject to regular deformations
or shear forces such as lungs, bladder, skin and vasculature
endothelium (Coste et al., 2010; Ranade et al., 2014; Li et al.,
2015). To date, however, very little is known about the role
of Piezo1 in the CNS. We have recently shown that Piezo1 is
involved in axon guidance of optic tract retinal ganglion cells
(RGCs) in the developing Xenopus laevis brain (Koser et al.,
2016). Here, we will investigate if glial cells can physically
sense and respond to the accumulation of amyloid plaques
by quantifying expression of astrocytic Piezo1 channels in the
hippocampus and cerebral cortex of the aging TgF344-AD rat
model of AD.
Because of their advanced age, elderly people are prone to
co-morbidities and peripheral infections that cause low-grade
systemic inflammation (Salles and Mégraud, 2007; Doulberis
et al., 2018). Interestingly, peripheral infections increase older
people’s risk of developing AD (Holmes et al., 2009; Tate et al.,
2014) and reportedly exacerbate amyloid plaque deposition in the
mouse brain (McManus et al., 2014), although the mechanisms
underlying this crosstalk between the periphery and CNS is
not well-understood. Although most transgenic animal models
recapitulate many of the amyloid-related hallmarks of AD, it is
important to use clinically-relevant animal models with at least
one comorbidity, such as a peripheral infection, to investigate AD
pathogenesis. Therefore, we investigated if a peripheral urinary
tract infection (UTI) with E. coli bacteria, one of the most likely
causes of infection in elderly people with dementia (Natalwala
et al., 2008; Rowe and Juthani-Mehta, 2013), modifies astrocytic
mechano-responsiveness to stiff extracellular amyloid deposits
(Leyns and Holtzman, 2017). Our results suggest that restoring
homeostatic mechanotransduction pathways and neuron/glial
crosstalk around amyloid plaques may lead to the discovery of
novel drug targets for neurodegeneration and AD.
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MATERIALS AND METHODS
Ethics Statement
All experiments involving animals and Schedule 1 protocols used
to obtain brain tissue were approved by the Animal Welfare and
Ethical Review Bodies (AWERB committees) of the University of
Brighton and The University of Manchester, as well as the Animal
Research Ethics Committee (AREC) in Trinity College Dublin.
This study was conducted in accordance with the principles of
the Basel Declaration and adhered to the legislation detailed in
the United Kingdom Animals (Scientific Procedures) Act 1986
Amendment Regulations (SI 2012/3039). All efforts were taken
to maximize animal welfare conditions and to reduce the number
of animals used in accordance with the European Communities
Council Directive of September 20th, 2010 (2010/63/EU).
Mouse Neuron Cultures
Primary neuron cultures were prepared from the cerebral cortical
tissue of male and female postnatal day 0 or 1 (P0 or P1) C57BL/6
mice bred in the BioResources Unit (BRU) of University of
Brighton. Briefly, cortices were dissected following decapitation
and collected in Ca2+- and Mg2+-free Hank’s balanced salt
solution (HBSS) (Thermo Fisher Scientific, 14185052). Cells were
dissociated using Papain [20 U/mL] (Worthington, 3119) in
Ca2+- and Mg-free HBSS supplemented with L-cysteine [1 mM]
(Sigma, 168149), EDTA [0.5 mM] (Thermo Fisher Scientific,
15575020) and DNAse I solution [0.125 U/mL] (Thermo Fisher
Scientific, 90083). Dissociation was inhibited using Type II-O
ovomucoid trypsin inhibitor [0.1%] (Sigma, T9253) in HBSS
with bovine serum albumin [0.1%] (Sigma, A9647) and D-
APV [D-(-)-2-Amino-5-phosphonopentanoic acid] [50 µM]
(Abcam, ab120003). A single-cell suspension was created by
gentle manual trituration using fire-polished Pasteur pipettes.
Cells were plated on Poly-D-Lysine (Millipore, A-003-E) coated
coverslips in 24-well plates [6 × 104 cells/well] with serum-
free Neurobasal-A medium (Life Technologies, 10888-022)
supplemented with 2% B27 (Thermo Fisher Scientific, 17504044)
and L-glutamic acid [25 µM] (Sigma, G1251). Primary neuron
cultures were maintained at 37◦C and 5% CO2 in a humidified
incubator and after 1 day in vitro, half of the plating medium
was replaced with maintenance medium (without L-glutamic
acid) composed of Neurobasal-A medium supplemented with
2% B27, 2 mM GlutaMAXTM (Gibco, 35050061), and 1%
penicillin/streptomycin (Thermo Fisher Scientific, 15140122).
This was repeated every 3 days, i.e., 50% of the cell culture
medium was replenished with fresh maintenance medium. After
14 days in culture, cells were fixed in ice-cold formalin solution
(10%) for immunofluorescent labeling.
Mouse Astrocyte Cultures
Mixed glial cell cultures were prepared from the cerebral
cortical tissue of male and female P1 wild-type C57BL/6 mice
bred in the BioResources Units of Trinity College Dublin
and University of Brighton, following previously described
protocols (O’Sullivan et al., 2017, 2018). Briefly, following
decapitation the cortices were dissected with sterile forceps
and placed in HBSS (Gibco, 14025-050). Cortical tissue was
cross-chopped with a sterile scalpel and then placed in pre-
warmed Dulbecco’s modified Eagle’s medium/F12 (DMEM/F12,
Hyclone, SH30023) supplemented with 10% FBS (Labtech; FB-
1090) and 1% penicillin/streptomycin (Sigma, P4333) and gently
triturated until a clear solution was obtained. The resulting
solution was passed through a cell strainer (40 µm) and plated
into separate T75 flasks. Cells were cultured at 37◦C and 5%
CO2 in a humidified incubator and grown in the supplemented
DMEM/F12 media previously described. After 12 days in culture,
microglial cells were separated from mouse astrocytes by placing
them on a rotating shaker for 2 h at 37◦C. The supernatant,
with detached microglia, was removed and the enriched astrocyte
cultures were trypsinised with 0.5% trypsin for 7 minutes (min)
and plated accordingly. Mouse astrocyte purity was >97%, as
previously described (Healy et al., 2013).
Aβ1−42 Conditioned Microglial Media
Microglial cultures were prepared from the cerebral cortical
tissue of male and female P1 wild-type C57BL/6 mice bred in
the BioResources Unit of Trinity College Dublin, as previously
described (Dempsey et al., 2017). Briefly, after 48 h in culture,
microglia were treated with 10 µM amyloid-β1−42 peptide
(Invitrogen, United Kingdom) for 24 h. Aβ1−42 conditioned
microglial media (CMM) was collected and used to treat the
enriched astrocyte cultures described above.
Immunocytochemistry
After each biochemical treatment, mouse astrocytes were fixed
in 10% formalin solution (Sigma, F1635) for 5 min on ice.
Cells were blocked overnight at 4◦C in blocking solution, i.e.,
1% BSA + 0.1% Triton X-100. Primary antibodies included
chicken anti-neurofilament H (NFH; Millipore, AB5539, RRID:
AB_177520) 1:1000 dilution, rabbit anti-GFAP (Abcam, ab7260,
RRID: AB_305808) 1:1000 dilution, goat anti-PIEZO1 (N-15;
Santa Cruz, sc-164319, RRID: AB_10842990) 1:500 dilution, and
rabbit anti-FAM38A (Abcam, ab128245, RRID: AB_11143245)
1:500 dilution in blocking solution, were used and incubated
overnight at 4◦C. Cells were washed with PBS + 0.1% Triton X-
100 for 5 min, three times. Incubations with secondary antibodies
were performed in the dark at 22 ± 2◦C for an hour. In
the case of rabbit anti-FAM38A, it was also incubated with
biotinylated goat anti-rabbit antibody (Thermo Fisher, A24535,
RRID: AB_2536003) and avidin Alexa 488 conjugate (Life
Technologies, A21370) to amplify the fluorescent signal. After
washes, cells were coverslipped and mounted on a microscope
slide (Clarity, C361) with antifade reagent (Thermo Fisher
S36936). Imaging was performed using a Leica SP8 confocal
microscope.
Western Blotting
Mouse astrocyte samples were obtained by scraping the cells
in radioimmunoprecipitation assay buffer (RIPA) containing
150 mM NaCl (Sigma, A3014), 1% Triton-X (Sigma, T8787),
0.1% SDS (Fisher, S/5200/53) and 50 mM Tris pH 8.0
(Fisher, T/3710/60). Samples were sonicated three times for
10 s at 20% amplitude using a vibracell VCX 130 (Sonics,
Frontiers in Aging Neuroscience | www.frontiersin.org 3 October 2018 | Volume 10 | Article 332
fnagi-10-00332 October 17, 2018 Time: 13:57 # 4
Velasco-Estevez et al. Astrocytic Piezo1 and Alzheimer’s Disease
United States). Briefly, samples were mixed in 1:1 dilution
with Laemmli sample buffer 2× (BioRad, 161-0737) and boiled
at 95◦C for 5 min. They were run in a 6% polyacrylamide
separating gel with 4% stacking gel (Applichem Panreac,
A1672) in running buffer at constant voltage 120 V, followed
by wet transfer to a PVDF (Millipore, IPVH00010) for
3 h at constant 70 V on ice. Blocking of the membrane
was done with 5% BSA (Santa Cruz, sc-2323) in 0.05%
PBS/Tween 20 for an hour at 22 ± 2◦C. Incubation with
primary antibody rabbit anti-FAM38A (Abcam, ab128245, RRID:
AB_11143245) or goat anti-PIEZO1 (Santa Cruz, sc-164319,
RRID: AB_10842990) was performed at a 1:500 dilution for
48 h at 4◦C. The membrane was washed and incubated
with secondary antibody HRP-conjugated goat anti-rabbit (GE
Healthcare, NA934, RRID: AB_772206) or HRP-conjugated
rabbit anti-goat (Sigma, A4174, RRID: AB_258138), respectively,
at 1:5000 dilution for 2 h at 22◦C. Following further washes,
membranes were developed using chemiluminescent HRP
substrate (Millipore, WBKLS0500) in a Fujifilm LAS-3000
(Fujifilm, Japan).
Wild-Type Rats
Female Lister hooded rats (Harlan Laboratories,
United Kingdom) were socially housed in groups of four
and given ad libitum access to food and water. The holding
room was kept on a 12 h light/dark cycle at 22 ± 2◦C.
Postnatal day 37 (5-weeks) rats were sacrificed by pentobarbital
overdose (intraperitoneal injection) and death was confirmed
by decapitation. Immunohistochemical experiments were
conducted using post-mortem brain tissue. All experiments
on animal tissue were performed in accordance with the
United Kingdom Animals (Scientific Procedures) Act 1986
Amendment Regulations (SI 2012/3039).
TgF344-AD Rats
Two male and female WT Fisher and TgF344-AD (TG) rats
with the APPSWE and PSEN11E9 mutations were purchased
from Prof T. Town laboratory (University of Southern California,
United States) and were set-up as breeding pairs in-house at the
Biological Services Unit (BSU) in The University of Manchester,
United Kingdom. TG rats and WT littermates were randomly
split into four groups, i.e., WT and TG non-infected (WT/TG)
and infected (iWT/iTG), bearing in mind that the UTI needed
to be performed on the entire box of rats. The number of rats per
group (n) were as follows; 12m WT (n = 5); 18m WT (n = 5); 12m
TG (n = 6); 18m TG (n = 6); 12m iWT (n = 5); 18m iWT (n = 5);
12m iTG (n = 6); 18m iTG (n = 6). All animals were housed in
groups of 2–4 in cages with individual ventilation, environmental
enrichment and constant access to food and water. A 12 h
light/dark cycle was used, with light from 7 am until 7 pm. All
experiments were carried out following internal ethical review
and approval by the AWERB committee of The University of
Manchester.
Urinary Tract Infection
A UTI was administered to the iWT and iTG groups at 7–8,
10–11, 13–14, and 16–17 months of age using Escherichia coli
(E. coli) UTI89. For infections at 7–8 and 10–11 months of age,
a concentration of 1.3 × 109 colony forming units/mL (cfu/mL)
was used, and for infections at 13–14 and 16–17 months of age,
a concentration of 2.6 × 109 cfu/mL was used. Therefore, before
sacrifice, 12-month rats received two rounds of infection and 18-
month rats received four rounds. Prior to infection, stocks of
E. coli were stored as 1.02 × 1011 cfu/mL in 15% glycerol and
were rapidly thawed and brought to the correct concentration
using sterile PBS. Rats were anesthetized and infected with 0.1 mL
of E. coli UTI89 by inserting a catheter (polyethylene tubing
covering 30-G hypodermic needles) into the urethra and injecting
the inoculum into the bladder. Prior to infection, buprenorphine
(0.03 mg/kg) was administered and the animals’ bladders were
emptied by gently pressing on the abdomen to release any bladder
content. Infected animals were placed into clean cages and were
monitored for 5 days for signs of illness. Urine samples were
taken 2 and 5 days post-infection to confirm infection levels.
Urine was plated on CLED agar plates and incubated at 37◦C for
18–24 h after which colony forming unit counts were performed
and scored according to the following classification system:
0 = Zero colonies; 0.5 = Scanty growth (<5 cfu); 2 = Scanty
growth (<20 cfu); 3 = moderate growth (>20 cfu); 4 = confluent
growth. Non-infected rats tested for infection all scored ≤ 0.5.
Tissue Sectioning
Coronal slices of Lister hooded rat brains (3–4 mm thick) were
fixed in 10% formalin solution for 8 h at 4◦C and then transferred
to 30% sucrose solution overnight (4◦C) for cryoprotection. Brain
slices were then covered in OCT (Optimal Cutting Temperature
compound) and frozen and stored at −80◦C. The slices were
cryosectioned (14 µm thick) coronally at approximately −3.0
and −10.8 mm with respect to Bregma (Paxinos and Watson,
2014) in order to reveal the dorsal hippocampus and cerebellum
regions, respectively. Cryosections were adhered to glass slides
coated with poly-L-lysine solution [0.1% (w/v) in H2O, Sigma].
Sections were permeabilized using a solution of 0.1% TritonTM
X-100 (Sigma) in PBS for 25 min.
TgF344-AD and WT rats were sacrificed using an isoflurane
overdose, confirmed by cervical dislocation. The brains were
collected, snap frozen using isopentane on dry ice and stored
at −80◦C. Sagittal brain sections (20 µm thick) between 1 and
3.36 mm lateral to Bregma were taken using a cryostat (Leica
CM3050s, Leica Biosystems Nussloch GmbH, Germany) and
stored at −80◦C. Prior to immunofluorescence, frozen sections
were allowed to air dry at 22 ± 2◦C for 20 min before fixation
in 70% ethanol for 30 min. They were permeabilized in 0.2%
Triton-X/PBS for 30 min, followed by several PBS washes, and
then blocked with 5% BSA/PBS for 1.5 h at 22± 2◦C.
Immunohistochemistry
Sections from WT Fisher and TgF344-AD rats were incubated
overnight at 22 ± 2◦C with the following primary antibodies,
(1) 1:500 dilution of goat anti-PIEZO1 (N-15; Santa Cruz,
sc-164319, RRID: AB_10842990), an affinity-purified goat
polyclonal antibody raised against a peptide mapping to the
N-terminus of PIEZO1 of human origin; (2) 1:1000 dilution
of rabbit anti-amyloid β1−42 (mOC98, Abcam, ab201061), a
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conformation-specific antibody that recognizes a discontinuous
epitope of Aβ that maps to segments AEFRHD and EDVGSNK;
(3) 1:1000 dilution of chicken anti-GFAP (Abcam, ab4674, RRID:
AB_304558). Slides were then washed in PBS and incubated for
4 h at 22◦C with the following secondary antibodies, (1) donkey
anti-goat Alexa 488 (Abcam, ab150133), (2) donkey anti-rabbit
555 (Sigma, SAB4600061), (3) donkey anti-chicken IgY (H + L)
CFTM 633 (Sigma, SAB4600127). Finally, slides were washed and
coverslipped using ProLong R© Gold antifade mounting medium
with DAPI (Life Technologies, United Kingdom, P36935).
Microscopy and Image Analysis
All images used to quantify Piezo1 expression in sagittal
cryosections were captured using an Axio Scan.Z1 slide
scanner (Zeiss, Germany) with a 20× magnification objective
(Plan-Apochromat). Individual images were montaged together
automatically in ZEN software (Zeiss, Germany) to reconstruct
a single image of the whole brain section. For quantitative
fluorescence intensity analysis, all images were captured in a
single uninterrupted run (∼50 h imaging time) and uniform
microscope settings were maintained throughout the session. The
images were exported as 8-bit tif files for Piezo1 fluorescence
intensity quantification. Image analysis was conducted using the
software package FIJI1. Briefly, Piezo1 expression was quantified
by manually selecting 10 regions of interest (ROI) for each
brain structure and calculating the average fluorescence intensity
within each ROI. Two or three brain sections from 5 or 6 different
animals per age group/genotype were analyzed (n = 5–6). More
specifically, the number of rats per group were as follows; 12m
WT (n = 5); 18m WT (n = 5); 12m TG (n = 6); 18m TG (n = 6);
12m iWT (n = 5); 18m iWT (n = 5); 12m iTG (n = 6); 18m
iTG (n = 6). Therefore, 100–180 fluorescence intensity (ROI)
measurements were captured depending on the age and genotype
of the rat. Piezo1 fluorescence intensities were normalized to
the 12m WT value for each region and the percentage (%)
change relative to the 12m WT group is represented in each
bar graph. To quantify Piezo1 expression in amyloid plaque-
reactive astrocytes versus astrocytes located at least 200 µm
away from any noticeable amyloid deposits, 25 plaques from
the frontal cortex of 18m TG rat brains were randomly selected
for analysis. For each image (25 in total) Piezo1 fluorescence
intensity was quantified in six astrocytes within the plaque core
and in six astrocytes ∼200–500 µm away from the plaque. The
average Piezo1 fluorescence intensity values for astrocytes located
“outside” the plaque versus “inside” the plaque were calculated for
each image, i.e., 150 astrocytes per group were analyzed.
Statistical Analysis
All statistical analysis was performed using GraphPad R© Prism
7 (RRID: SCR_015807). Assessment of the normality of data
was carried out using column statistics with D’Agostino analysis
before any other statistical test was performed. For Western
blot assays, repeated measures analysis of variance (ANOVA)
tests were performed because data in every experiment was
matched. Holm-Sidak multiple comparisons post hoc tests were
1http://fiji.sc/Fiji
run in conjunction with one-way ANOVAs and all groups
were compared with one another. Data are presented as the
mean± standard error of the mean (SEM). To analyze changes in
Piezo1 fluorescence intensities in vivo, where three independent
variables (i.e., age, genotype, and infection) were present, a three-
way ANOVA was performed on the raw fluorescence values,
followed by a Holm-Sidak multiple comparisons post hoc test.
Changes in Piezo1 expression in vivo were only considered
significant when they passed two criteria, i.e., the relative
percentage (%) change was > 20% and the p-value < 0.01.
To analyze differences in average astrocytic Piezo1 expression
outside versus inside amyloid plaques in the frontal cortex of 18m
TG rat brains, a two-tailed paired t-test was performed. Finally,
to correlate Piezo1 expression in the DG with that of GFAP and
Aβ1−42 fluorescence intensities, Pearson r-values were calculated
using the raw fluorescence intensity values. A correlation was
only deemed significant if r > 0.5 and p< 0.0001.
RESULTS
Mechanosensitive Piezo1 Channel
Expression in the Juvenile and Adult Rat
Brain
To characterize Piezo1 channel expression in distinct regions
of the young rat brain, coronal sections were cut at −3.0
and −10.8 mm with respect to Bregma revealing hippocampal
(Figure 1A) and cerebellar (Figure 1B) structures. In agreement
with our previous findings in the brain of embryonic Xenopus
laevis (Koser et al., 2016), the juvenile rat optic tract expresses
relatively high levels of Piezo1 channels (Figure 1A, red arrow).
Moreover, axonal tracts of the corpus callosum, hippocampal
fimbriae, and arbor vitae of the cerebellum (Figure 1B, white
arrow) express high levels of Piezo1 channels. In contrast,
the molecular and granule layers of the cerebellum, and
non-neuronal areas of the hippocampus, express much fewer
Piezo1 channels (Figures 1A,B). These regional differences were
confirmed by Western blot (WB) using two distinct antibodies,
i.e., one which binds the N-terminus of Piezo1 (Santa Cruz;
Figures 1C,D) and one that binds the C-terminus (Abcam;
Figures 1E,F). For WB, the brains of juvenile rats were dissected
into four areas, i.e., cerebellum (Crb), hippocampus (Hip),
cerebral cortex (Ctx), and brain stem/thalamus (BS/T) combined.
There were no statistically significant differences in Piezo1
expression between brain structures (repeated measures one-
way ANOVA, p > 0.05). However, the hippocampus consistently
displayed lower levels of Piezo1, both with immunofluorescence
and WB techniques.
Next, sagittal sections from adult (12 months) rat brains
were imaged to characterize Piezo1 localisation in several other
structures along the anterior–posterior axis (Figures 2A–D).
Similar to juvenile rats, Piezo1 was highly expressed along axonal
tracts of the corpus callosum and cerebellar arbor vitae as well
as on Purkinje cell bodies (Figure 2J), medulla, pons, thalamus
(Figure 2M) as well as on Purkinje cell bodies (Figure 2J),
medulla, pons, thalamus (Figure 2M), striatum (Figure 2N) and
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FIGURE 1 | Piezo1 channels are highly expressed by neurons in the optic tract, corpus callosum, and arbor vitae of the cerebellum. Coronal sections of the 5-week
old rat brain were cut at –3.3 mm (A) and –10.8 mm (B) with respect to Bregma and immunofluorescently stained for Piezo1 (N-terminal antibody) (n = 4), scale
bar = 4,000 µm. The red arrow points to the optic tract in the right hemisphere and the white arrow points to the arbor vitae of the Ansiform lobule Crus 1 of the
cerebellum. 5-week old rat brains were also dissected into four parts for Western blotting (WB), i.e., cerebellum (Crb), hippocampus (Hip), cerebral cortex (Ctx) and
brainstem/thalamus (BS/T). WB were run for Piezo1 using an N-terminal binding antibody (C,D) from Santa Cruz (n = 3) and a C-terminal binding antibody (E,F) from
Abcam (n = 3). The hippocampus consistently showed the lowest levels of Piezo1 protein expression.
the rostral migratory stream which links the subventricular zone
to the olfactory bulb (Figure 2B, blue arrow). Areas of low Piezo1
expression included the dorsal midbrain (Figure 2K) and non-
neuronal regions of the hippocampus. Pyramidal and granule
neurons of the CA1 (Figure 2E), CA3 (Figure 2F), and dentate
gyrus (Figure 2G), however, expressed higher levels of Piezo1.
Interestingly, layer V cortical cells (Figure 2H) expressed more
Piezo1 channels than prefrontal cortical cells (Figure 2I). It
was also noted that epithelial cells of the choroid plexus within
the lateral ventricle (Figure 2L) express relatively high levels of
Piezo1 protein.
Reactive Astrocytes Surrounding
Amyloid Plaques Upregulate Piezo1
The pattern of expression in the rat brain suggested that Piezo1 is
predominantly localized to neurons, in agreement with human
studies of mRNA (Satoh et al., 2006). To examine if Piezo1
protein expression in mouse brain in situ matched that of the rat
brain at the same age, we sectioned and immunofluorescently-
labeled juvenile (5 weeks) mouse brains for Piezo1 and observed
a strikingly similar expression pattern to the young rat brain; a
result that matches the highly conserved amino acid sequence
between mouse and rat Piezo12. It was noted that Piezo1
expression in mouse brain also appeared predominantly neuronal
(data not shown). To confirm cellular localisation, primary
neuron cultures and enriched astrocyte cultures (∼97% pure)
were prepared from newborn C57BL/6 mice and double-stained
for either Piezo1 and GFAP (Figures 3A–D) or Piezo1 and
2http://www.uniprot.org/
neurofilament H (NFH; Figures 3E–H). Piezo1 co-localized with
neurofilament H in mouse cortical neurons but was almost
completely absent from primary astrocyte cultures under basal
conditions.
To investigate if neuroinflammatory cell stressors are capable
of upregulating Piezo1 channels in astrocytes, we exposed
astrocytes to 5 µM hydrogen peroxide (H2O2) or to a cytokine
cocktail consisting of TNF-α (10 ng/mL) and IL17A (250 ng/mL)
for 24 h. Neither stressor induced Piezo1 expression in astrocytes
(Figures 3M,N). Satoh et al. (2006), however, have reported
previously that Piezo1 mRNA (then known as membrane protein
induced by beta amyloid, Mib), is upregulated in astrocytes
surrounding amyloid plaques in human post-mortem brain
tissue. To examine if mouse astrocytes in culture can also
be forced to express Piezo1 under similar pathophysiological
conditions, we first treated mouse microglial cells with 10 µM
amyloid beta-42 (Aβ1−42; Invitrogen, United Kingdom) for
24 h and collected the inflammatory cell culture media. Mouse
astrocytes were then incubated with Aβ1−42 CMM for 48 h
and stained for Piezo1 channels (Figures 3I–L). Aβ1−42 CMM
induced Piezo1 expression in 30–40% of cortical astrocytes
(Figures 3I,M,N).
Next, we investigated if upregulation of Piezo1 channels is
also evident in vivo in an aging rat model of Alzheimer’s disease
pathology (TgF344-AD). To achieve this, the brains of 18-month
old TgF344-AD (18m TG) rats were sectioned in the sagittal
plane and triple-immunolabeled for Piezo1, conformation-
specific Aβ1−42 [mOC98], and GFAP. High magnification
(100×) z-stack projections clearly demonstrate an upregulation
of Piezo1 in reactive astrocytes surrounding prefrontal cortical
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FIGURE 2 | Piezo1 channel expression in the adult rat brain. (A) The brains of adult (12 month) Fisher rats were sectioned in the sagittal plane (lateral –1.9 mm) and
stained for (B) Piezo1 (N-terminal antibody), (C) DAPI, and (D) GFAP (n = 5). Images were captured using a 20× magnification objective on an Axio Scan.Z1 slide
scanner (Zeiss, Germany) and montaged in ZEN software. 20× magnification images of the hippocampal (E) CA1 (scale bar = 150 µm), (F) CA3 and (G) dentate
gyrus (DG) show that Piezo1 expression is greater in pyramidal and granule neurons compared to GFAP-positive astrocytes. In the cerebral cortex, (H) layer V
pyramidal neurons (LV Ctx) appear to express more Piezo1 channels than (I) prefrontal cortical (PFC) neurons. In the cerebellum (J), Purkinje neuron cell bodies and
axons (arbor vitae) express higher levels of Piezo1 compared to neurons in the granule and molecular cell layers. (K) The dorsal midbrain (DM) expresses moderate
levels of Piezo1, whereas (L) epithelial cells of the choroid plexus (CP) express greater amounts of Piezo1 protein. It was also noted that white matter tracts in (M)
the thalamus (Th) and (N) striatum (Str) express more Piezo1 than gray matter areas of these brain regions. The areas depicted in images (E–N) are shown as yellow
boxes in (C). Relative fluorescence intensity (arbitrary fluorescence units, a.f.u.) of Piezo1 staining in each brain region was quantified (O). Axonal tracts including the
cerebellar arbor vitae, hippocampal fimbriae, cingulum and corpus callosum, as well as the medulla and pons of the brainstem, had the highest expression of Piezo1
protein.
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FIGURE 3 | Aβ1−42 CMM upregulates Piezo1 expression in cortical astrocyte cultures. To check cellular localisation of Piezo1 in the brain, enriched astrocyte
cultures (A–D) and cortical neuronal cultures (E–H) from newborn mice were stained for (A,E) Piezo1 (N-terminal antibody) and (C) GFAP or (G) neurofilament H
(NFH), respectively (n = 3). Piezo1 co-localized with NFH staining in neurons (H) but was almost completely absent from astrocytes under basal conditions (D). To
investigate if neuroinflammatory stimuli can induce Piezo1 expression in astrocytes, mouse microglia were exposed to human Aβ1−42 (Invitrogen, United Kingdom)
for 24 h and the inflammatory media was collected. Enriched mouse astrocyte cultures were then exposed to this Aβ1−42 CMM for 48 h. Astrocytes were
immunofluorescently stained for (I) Piezo1 (C-terminus antibody), (J) DAPI, (K) GFAP, and (L) is the merge of each channel. Scale bar = 20 µm. Exposure to Aβ1−42
CMM upregulated Piezo1 protein expression in approximately 30–40% of astrocytes (M,N). Astrocytes were also treated for 24 h with either 5 µM hydrogen
peroxide (H2O2) or a cytokine cocktail consisting of TNF-α (10 ng/mL) and IL17A (250 ng/mL). Neither H2O2 nor TNF-α/IL17A increased Piezo1 expression
indicating that Piezo1 upregulation is not a common response to all cell stressors but specific to certain inflammatory stimuli including Aβ1−42 and factors released
by reactive amyloid-stimulated microglia. Data are represented as mean ± SEM (n = 8). A repeated measures one-way ANOVA with Holm-Sidak post hoc test was
performed. ∗Represents a statistically significant difference (p < 0.05) from control (Ctrl), TNF-α/IL17A, and H2O2 treatment groups.
amyloid plaques (Figures 4A–E). On average, there was a
threefold upregulation in Piezo1 expression in amyloid plaque-
reactive astrocytes compared to astrocytes located at least 200 µm
away from any plaque in the prefrontal cortex (Figures 4F,G).
One must remember, however, that GFAP staining only covers
∼15% of the total volume of astrocytes (Sun and Jakobs, 2012)
and therefore, the reported percentage of cells expressing Piezo1
might be somewhat of an underestimation. Interestingly, in vivo
Piezo1 expression closely matches our in vitro results following
incubation of enriched astrocyte cultures with Aβ1−42 CMM, i.e.,
only a proportion of astrocytes (∼30%) express Piezo1 channels
and the expression appears perinuclear in reactive astrocytes
in vivo.
Aging and Amyloid Plaque Pathology
Increase Piezo1 Expression in Anterior
Cortical Regions
We next characterized spatiotemporal changes in Piezo1
expression in different areas of the cerebral cortex in
12- and 18-month old wild-type (WT) and TgF344-AD
(TG) rats. Low magnification (20× montage) images of the
prefrontal cortex reveal an upregulation of Piezo1 and GFAP
around amyloid plaques (Figures 5A–J). Piezo1 expression in the
prefrontal cortex increased 32 ± 3% from 12 to 18 months
of age in WT rats (Figure 5K; p < 0.0001). However,
frontoparietal (Figure 5L) and audiovisual (Figure 5M)
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FIGURE 4 | Aβ1−42 pathology in vivo upregulates Piezo1 expression in astrocytes surrounding amyloid plaques. 18-Month old TgF344-AD rat brains were
immunofluorescently stained for (A) conformation-specific Aβ1−42, (B) GFAP, (C) Piezo1 (N-terminal antibody), and (D) DAPI. Scale bar = 40 µm. (E) High
magnification (100× objective) z-stack projections of prefrontal cortex amyloid plaques reveal an upregulation of GFAP in reactive astrocytes surrounding the amyloid
plaque. Piezo1 protein is also upregulated in a proportion of astrocytes in and around the core of the plaque. Piezo1 appears localized predominantly to the
perinuclear compartment of Aβ1−42 reactive astrocytes. (F) Astrocytic Piezo1 fluorescence intensity was calculated for astrocytes inside the amyloid plaque versus
astrocytes located 200–500 µm away from any noticeable plaque deposits. Piezo1 fluorescence intensity was averaged for six astrocytes “inside” and six astrocytes
“outside” the plaque and 25 images from the frontal cortex of 18 m TG rats (n = 6) were analyzed. There was no correlation (Pearson r = 0.468) between Piezo1
expression inside versus outside amyloid plaques. (G) However, on average there was a 190% increase in Piezo1 expression in astrocytes within the plaque core
(Inside) versus astrocytes at least 200 µm away from the edge of any amyloid plaque (Outside). A two-tailed paired t-test was performed. ∗Represents a statistically
significant difference (p < 0.001) inside versus outside of the plaque.
cortical regions did not display any significant changes
in Piezo1 expression in WT rats from 12 to 18 months.
Piezo1 channel expression also increased in the prefrontal
(34 ± 2%) and frontoparietal (31 ± 2%) cortices of TG rats
from 12- to 18-months of age but not in the audiovisual area
(17 ± 2%). Taken together, both aging and amyloid plaque
pathology trigger increases in Piezo1 channel expression,
particularly in the prefrontal cortex, of TgF344-AD rats
(Figures 5K–N).
Peripheral Bacterial Infection Enhances
Piezo1 Expression in the Cerebral Cortex
of TgF344-AD Rats
Twelve month old TgF344-AD rats had previously been exposed
to a UTI (E. coli) at 8 and 11 months of age (iTG). This bacterial
infection caused a significant upregulation of Piezo1 channels in
the prefrontal (21± 3%; Figure 5K) and frontoparietal (23± 3%;
Figure 5L) cortices of 12-month old iTG rats, but not the
audiovisual cortex (16 ± 2%; Figure 5M). In contrast, in older
18-month iTG rats that had been infected with E. coli at 8,
11, 14, and 17 months of age, no changes in Piezo1 channel
expression were measured in prefrontal (12± 2%; Figure 5K) or
frontoparietal (12 ± 3%; Figure 5L) cortices compared to non-
infected TgF344-AD counterparts. However, Piezo1 expression
in the audiovisual cortex did display significant upregulations
(21 ± 3%; Figure 5M) in 18-month iTG rats in response to
repeated peripheral infections. Interestingly, peripheral E. coli
infections did not increase Piezo1 expression in the prefrontal
cortex of WT rats at 12 months (15 ± 3%) nor at 18 months
(12 ± 3%) of age compared to WT controls. Taken together, our
results indicate that repeated UTI enhances Piezo1 expression in
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FIGURE 5 | Mechanosensing Piezo1 channel expression increases in the cerebral cortex of TgF344-AD rats with a urinary tract infection (UTI). Sagittal sections
(lateral –1.9 mm) of wild-type (WT) Fisher and TgF344-AD rat brains were immunofluorescently stained for Piezo1 (N-terminal antibody), conformation-specific
Aβ1−42, GFAP, and DAPI. Shown are representative images of the prefrontal cortex of an 18-month WT rat (A–E) and an 18-month TgF344-AD (18 m TG) (F–J).
Scale bar = 150 µm. Elevations in Piezo1 channel expression with age, Alzheimer’s disease (AD) pathology and peripheral infection were measured in three distinct
areas of the cerebral cortex, i.e., the prefrontal cortex (K), the frontoparietal cortex (L), and the audiovisual cortex (M). In addition, Piezo1 expression was averaged
over all three regions to illustrate changes in channel expression in the total cerebral cortex (N). Data were normalized to 12 month wild-type (12m WT) values for
each cortical region and are represented as the mean ± SEM of the percentage change from the 12m WT groups. Three-way ANOVAs with Holm-Sidak post hoc
tests were performed to test for interactions between age, genotype, and peripheral infection. ∗Represents a change > 20% and a p-value < 0.01. There were 5–6
rats per group and 2–3 brain sections per animal. Ten regions of interest (ROI) were analyzed per cortical region per section, i.e., 100–180 ROIs analyzed per group.
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the cerebral cortex of TgF344-AD rats over and above that seen
in response to amyloid plaques alone (Figure 5N).
Piezo1 Upregulation in the Hippocampus
of TgF344-AD Rats Precedes Changes in
the Cerebral Cortex
Just as normal aging increased expression of Piezo1 channels in
the prefrontal cortex, increases in Piezo1 were also evident in
the CA1 (34 ± 4%) and DG (24 ± 3%) of the hippocampus,
but not in the CA3 region, from 12 to 18 months in WT rats
(Figures 6A–W). Notably, there were also large relative increases
in Piezo1 expression in the DG (99 ± 7%; Figure 6U), CA3
(58 ± 6%; Figure 6V) and CA1 (78 ± 6%; Figure 6W) of 12-
month TG rats compared to their 12-month WT conspecifics.
Interestingly, however, there were no further significant increases
in hippocampal Piezo1 expression in TG rats from 12 to
18 months of age, suggesting that amyloid deposition and plaque
load begin in the hippocampus before spreading further to
cortical regions.
Peripheral Infection Upregulates
Hippocampal Piezo1 Expression in
Wild-Type and TgF344-AD Rats
Unlike the cerebral cortex, upregulations in Piezo1 expression
were measured in the hippocampal CA1 region (28 ± 5%) in
response to peripheral E. coli infection at 12 months of age in
iWT rats (Figure 6W). However, no further increases in Piezo1
expression were evident in the CA1 of infected 18-month iWT
rats. Peripheral infection at 8 and 11 months did, however, cause
an upregulation of Piezo1 channels in the CA3 region of iTG rats
at 12 months of age (20 ± 7%; Figure 6V). Moreover, repeated
peripheral infection at 8, 11, 14, and 17 months of age caused
a large increase in Piezo1 channels in the dentate gyrus of 18-
month iTG rats (25 ± 8%) compared to their non-infected and
age-matched TG counterparts (Figure 6U).
Piezo1 Expression Strongly Correlates
With Amyloid Plaque Deposition in the
Hippocampal Dentate Gyrus
It is clear from our immunofluorescence data that both GFAP
reactivity and Piezo1 expression are greater around amyloid
plaques, especially in the hippocampus. Apart from the molecular
layer of the cerebellum, the dentate gyrus displayed the lowest
levels of Piezo1 expression in 12-month old WT rats (Figure 2O).
Because basal levels of Piezo1 in the DG are low, the relative
(%) increases in Piezo1 protein expression in 12-month old,
18-month old, and 18-month infected Tg-344AD rats were
large (Figure 6U). To assess the relationship between Piezo1
expression and amyloid plaque pathology in adult and aged rats
with and without repeated peripheral infections, we correlated
Piezo1 fluorescence intensity with both GFAP and Aβ1−42
expression in the dentate gyrus of all groups (Figure 7). In
agreement with our in vitro studies, Piezo1 expression did not
correlate with GFAP expression in 12-month WT, 18-month
WT, or 12-month iWT (Figures 7A–C). However, DG Piezo1
expression showed a moderate correlation with GFAP intensity
in 18-month iWT rats exposed to repeated peripheral infections
(Figure 7D; Pearson r = 0.523, p < 0.0001). Similarly, there
was no correlation between GFAP fluorescence intensity and
Piezo1 expression in the DG of 12-month TG, 18-month TG,
or 12-month iTG (Figures 7E–G). In 18-month iTG, however,
increases in GFAP reactivity in the DG did correlate with
increased Piezo1 expression (Figure 7H; Pearson r = 0.519,
p < 0.0001). Peripheral infection of older rats led to an
upregulation of GFAP in the hippocampal DG and these reactive
astrocytes were more likely to express Piezo1 channels. GFAP
expression in the DG of older iTG rats that had repeated
peripheral infections also correlated with high amyloid plaque
pathology (Figure 7L; Pearson r = 0.586, p < 0.0001), when
compared to 18-month TG rats without infection (Figure 7K).
Finally, Piezo1 expression in the DG displayed very strong
correlations with Aβ1−42 fluorescence intensity in 12- and
18-month TgF344-AD rats either with or without peripheral
infection (Figures 7M–P). This suggests that whilst peripheral
E. coli infection alone can upregulate astrocytic Piezo1; Aβ1−42
CMM and in vivo amyloid plaque pathology are stronger
triggers of mechanosensing Piezo1 channel expression in reactive
astrocytes.
DISCUSSION
TgF344-AD transgenic rats overexpress mutated human PSEN1
(PSEN11E9) and human APP with the Swedish mutation
(APPSWE) and were developed with the intention of creating
an improved animal model of AD that recapitulates a broader
spectrum of neuropathological features seen in the human
AD brain (Cohen et al., 2013). As such, TgF344-AD rats
display neuronal tau deposition in contrast to what is generally
observed in transgenic mice with these particular gene mutations
(Duyckaerts et al., 2008; Stancu et al., 2014). Unless tau-
associated genes are also mutated, transgenic mice tend not to
spontaneously form neurofibrillary tau tangles (Holcomb et al.,
1998; Jankowsky et al., 2001). By combining this improved
transgenic rat model with a UTI, a common comorbidity of
elderly people who develop AD, the model we present here more
closely mimics the systemic inflammation and the spatiotemporal
deposition of amyloid plaques observed in the hippocampus and
cortex of aging human AD subjects.
Utilizing the TgF344-AD rat model (Cohen et al., 2013), we
show here that Piezo1 protein expression increases in several
key brain structures in response to aging, peripheral infection
and amyloid plaque pathology. Piezo1 channels increase in
the prefrontal cortex and the hippocampal CA1 and dentate
gyrus with normal aging. These brain regions are particularly
important for processing salient sensory information (Barbas and
Zikopoulos, 2007; Lester et al., 2017), for learning and memory
(Kane and Engle, 2002; Guo et al., 2018) and for higher executive
functions (Arnsten and Li, 2005; Suwabe et al., 2017), all of which
deteriorate in the elderly (Zimprich and Kurtz, 2013; Thomé
et al., 2016; Wiegand et al., 2016). Since an increase in stretch-
activated Ca2+ channel expression could, in theory, predispose
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FIGURE 6 | Aging, Aβ1−42 pathology and peripheral infection upregulate Piezo1 expression in the hippocampus of TgF344-AD rats. Sagittal sections (lateral
−1.9 mm) of WT Fisher and TgF344-AD rat brains were immunofluorescently stained for Piezo1 (N-terminal antibody), conformation-specific Aβ1−42, GFAP, and
DAPI. Shown are representative images of the hippocampus of an 18-month wild-type (18m WT) rat (A–E), an 18-month TgF344-AD 18m TG (F–J), an 18-month
WT with infection (18m iWT) (K–O), and an 18-month TgF344-AD with infection (18m iTG) (P–T). TgF344-AD rats with and without an infection show clear
upregulations of GFAP (I,S) in hippocampal areas with dense amyloid deposition (H,R), particularly the hilus, the outer molecular layer of the dentate gyrus, and the
stratum oriens of the CA1. Moreover, amyloid plaques surrounded by a dense meshwork of GFAP-positive astrocytes generally showed concomitant upregulations
of Piezo1 expression, particularly in 18m TG rats with or without an infection (G,Q). Next, changes in Piezo1 expression with age, infection and genotype were
quantified in the neuronal cell body layers of the dentate gyrus (U), CA3 (V), and CA1 (W). Piezo1 expression increased from 12- to 18-months in WT rats in the DG
and CA1, but not CA3 neurons. A much more potent trigger of Piezo1 expression in the hippocampus, however, was genotype with TgF344-AD rats expressing
much larger levels of Piezo1 in the DG (U), CA3 (V), and CA1 (W) at 12-months of age. There were no further increases in Piezo1 expression in 18-month old
TgF344-AD rats. However, peripheral infection caused a significant increase in Piezo1 expression in the dentate gyrus (U) of TgF344-AD rats (18m iTG). Data were
normalized to 12m WT values for each hippocampal region and are represented as the mean ± SEM of the percentage change from the 12m WT groups.
Three-way ANOVAs with Holm-Sidak post hoc tests were performed to test for interactions between age, genotype, and peripheral infection. ∗Represents a change
of > 20% and a p-value < 0.01. There were 5–6 rats per group and 2–3 brain sections per animal. Ten ROI were analyzed per hippocampal region per section, i.e.,
100–180 ROIs analyzed per group.
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FIGURE 7 | Piezo1 expression in the hippocampal dentate gyrus correlates with GFAP in aged rats with peripheral infection and strongly correlates with amyloid
plaques in TgF344-AD rats. Sagittal brain sections were triple-stained for Piezo1, GFAP and conformation-specific Aβ1−42 and Pearson correlations (r values) were
performed to measure changes in Piezo1 channel expression in astrocytes (GFAP vs. Piezo1) with age and peripheral infection in WT (A–D) and TgF344-AD (E–H)
rats. There was a moderate Pearson correlation between GFAP and Piezo1 in the infected 18-month WT (r = 0.523) and infected 18-month TgF344-AD rats
(r = 0.519). However, the linear regression (R2) values were relatively weak for both groups suggesting that the GFAP fluorescence intensity is not a good predictor of
Piezo1 channel expression. Next, Pearson correlations were performed to measure changes in GFAP expression around amyloid plaques (GFAP vs. Aβ1−42) in the
dentate gyrus with age and peripheral infection in TgF344-AD rats (I–L). There was a moderate Pearson correlation between GFAP and Aβ1−42 in the infected
18-month old TgF344-AD rats (r = 0.586) but a relatively weak linear regression (R2) value suggesting that Aβ1−42 fluorescence intensity is not a good predictor of
GFAP expression. Finally, Pearson correlations were performed to measure changes in Piezo1 channel expression in and around amyloid plaques (Aβ1−42 vs.
Piezo1) in the dentate gyrus with age and peripheral infection in TgF344-AD rats (M–P). There were strong Pearson correlations between Aβ1−42 and Piezo1 in
12-month old TgF344-AD rats (r = 0.917), 12-month old TgF344-AD rats with peripheral infection (r = 0.736), 18-month old TgF344-AD rats (r = 0.770), and
18-month old TgF344-AD rats with peripheral infection (r = 0.856). In addition, the high linear regression (R2) values for each group (M–P) suggests that Aβ1−42
fluorescence intensity is a good predictor of Piezo1 channel expression in the dentate gyrus of TgF344-AD rats.
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aging neurons to Ca2+ dysregulations (Nagarajan et al., 2014),
it would be interesting to further investigate if Piezo1 channel
expression modulates neuronal Ca2+ homeostasis. Intrinsic
neuronal properties and synaptic plasticity are intimately linked
with tight control of cellular Ca2+ concentrations (Catterall
et al., 2013; Maggio and Vlachos, 2014) and, therefore,
mechanosensitive channels that regulate calcium levels may
play an important role in cognition in the aging hippocampus
or prefrontal cortex. In this regard, various members of the
transient receptor potential (TRP) channel family have been
implicated in both mechanosensation (Kwan et al., 2006) and
Ca2+ dysregulations in neurons and astrocytes in AD (Yamamoto
et al., 2007). In the present study, the age-dependent increases
in Piezo1 channel expression measured in the prefrontal cortex,
CA1 and DG of wild-type rats appeared predominantly neuronal
whereas in the TgF344-AD rat model, peripheral infection and
amyloid plaque pathology caused an upregulation of Piezo1
predominantly in reactive astrocytes, although concomitant
increases in neurons and reactive microglia are also likely to
occur. This is interesting because the role of Piezo1 in CNS
neurons could be different to its function in astrocytes since
neurons constitutively express mechanosensing Piezo1 channels
on axonal growth cones and the outer cell membrane, whereas
astrocytes exposed to neuroinflammatory stimuli, such as Aβ1−42
CMM, upregulate and accumulate Piezo1 channels within the
perinuclear compartment. Indeed, in epithelial cell types Piezo1
reportedly co-localizes with the endoplasmic reticulum where
it regulates intracellular Ca2+ release from stores (McHugh
et al., 2010). Moreover, separating the physiological role
of Piezo1-mediated extracellular calcium influx from Piezo1-
regulated Ca2+ release from intracellular stores will reveal
subsets of novel mechanotransduction cascades that originate
from either outer membrane-spanning Piezo1 channels or
from intracellular Ca2+ stores (Clapham, 2007). Our results
suggest that Piezo1 channels regulate glial mechanosensation and
may trigger astrogliosis in the AD brain. Moreover, amyloid
plaque-associated microglia and the biochemical factors they
release when activated likely play a key role in controlling
Piezo1 expression in reactive astrocytes. As such, TgF344-AD
rats infected with E. coli show enhanced Piezo1 expression
in the cortex and hippocampus compared to non-infected
transgenic animals. Moreover, microglia have been shown to
regulate the pathogenic activities of astrocytes in a mouse model
of multiple sclerosis (Rothhammer et al., 2018). Therefore,
determining whether Piezo1 regulates neurodegenerative or
neuroprotective mechanotransduction signaling in reactive
astrocytes surrounding amyloid plaques is an important topic for
future research.
Astrocytic Piezo1 in Alzheimer’s Disease
Satoh et al. (2006) discovered that astrocytes surrounding
amyloid plaques in the cerebral cortex of AD patients express
hMib mRNA. Coste et al. (2010) renamed Mib (also known
as FAM38A), Piezo1, and described how it forms a stretch-
activated calcium-permeable channel in the neuroblastoma
cell line, Neuro2A. Elegant new research has revealed the
tertiary structure of Piezo1 at near atomic level (Ge et al.,
2015) and describes how non-selective cationic channels are
formed from homotrimers which exhibit large mechanosensitive
‘propeller-like’ structures on the outer surface of membranes
(Coste et al., 2012; Li et al., 2014). Astrocytes are very sensitive
to changes in their local mechanical environment (Leipzig
and Shoichet, 2009; Blumenthal et al., 2014) and our data
suggests that perturbations caused by stiff amyloid plaques
trigger the transcriptional upregulation of mechanosensing
Piezo1 channels in astrocytes which are normally devoid of
Piezo1 protein (Figure 3E). But why might a sub-population of
reactive astrocytes upregulate mechanosensing Piezo1 channels?
Interestingly, Liddelow et al. (2017) showed that ∼60% of
GFAP-positive astrocytes in the prefrontal cortex of human AD
patients were of the A1 phenotype, i.e., a neurotoxic subtype
of reactive astrocyte that drives neuroinflammation and causes
neurotoxicity. It would be interesting to determine if the 30–
40% of Piezo1-expressing astrocytes around amyloid plaques
in the TgF344-AD rat model stain positive for A1 astrocyte
markers (e.g., Serping1), or for astrocytes of the A2 phenotype
(e.g., S100A10) which reportedly release neurotrophic factors
and are mainly neuroprotective (Liddelow et al., 2017). More
research is needed to determine what makes Piezo1-expressing
astrocytes around amyloid plaques different to their Piezo1-
negative neighbors and to characterize both subpopulations
based on their ‘neuroinflammatory phenotype.’
Piezo1 as a Regulator of Neuron/Glial
Communication
Blumenthal et al. (2014) suggest that neuronal Piezo1 is
important for sensing the topography of cells at the nanometre
scale. Hippocampal neurons cultured in vitro form many
neuron/glial interactions when grown on relatively smooth
glass substrates but blocking mechanosensitive channels with
GsMTx4, a peptide component of the Grammostola rosea
tarantula venom, promotes decoupling of neurons from
astrocytes and leads to fewer cell contacts. This suggests that
Piezo1 can regulate the physical communication between
neurons and astrocytes. Moreover, they also showed that
the surface topography of brain tissue becomes rougher in
response to amyloid plaque pathology which can increase
the nanoroughness of astrocytes, thus contributing to
neurodegeneration (Blumenthal et al., 2014). If Piezo1 does
indeed regulate neuron/glial communication in vivo, this
supports our previous work which revealed that Piezo1 channels
are involved in neuronal mechanosensation and axon guidance
during brain development (Koser et al., 2016), enabling
migrating growth cones to detect changes in the stiffness of
their local environment. Here, we confirm that the rat optic
tract also expresses relatively high levels of Piezo1 channels
(Figure 1A), as well as the corpus callosum and cerebellar arbor
vitae, suggesting that Piezo1 may play a more general role in
axonal pathfinding during brain development. Indeed, migrating
axons and growth cones are highly mechano-responsive and
likely receive constant feedback about the stiffness of the local
ECM or the apparent density of glial cell networks as they
grow through different brain regions toward their final targets.
Moreover, glial cells are softer than neurons (Lu et al., 2006)
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and recent studies have shown that SH-SY5Y cells (a human
neuroblastoma cell line) that overexpress mutated APPSWE are
stiffer than normal SH-SY5Y cells (Lu et al., 2017). Therefore,
astrocytes capable of engulfing and phagocytosing neurotoxic
Aβ1−42 peptides may change their mechanical properties or
surface topography in the AD brain. Neurons in contact with
reactive astrocytes that engulf neurotoxic amyloid peptides
may be able to sense a change in their cellular stiffness or
membrane nanoroughness and detach from them. Therefore,
widespread loss of cell contacts in the hippocampus and cortex,
or a disruption to neuron/glial communication caused by
changes in the mechano-responsiveness of cells, may accelerate
neurodegeneration (Blumenthal et al., 2014) and cognitive
decline in the AD brain.
Recent evidence also suggests that dysregulated
mechanosensitive signaling can contribute to astrogliopathy
in Alexander disease, leading to an increase in brain stiffness
(Wang et al., 2018). Alexander disease is a rare neonatal
neurodegenerative disorder caused by accumulation of
pathogenic Rosenthal fibers due to mutations in astrocytic
GFAP. In contrast, we have recently shown that glial scars
rich in GFAP- and Vimentin-expressing glial cells, which
form following cortical stab injury or contusive spinal cord
injury, are much softer than surrounding healthy CNS tissue
(Moeendarbary et al., 2017). Therefore, astrogliosis can
apparently lead to either increases or decreases in brain tissue
stiffness depending on the underlying causes of tissue injury
or disease. As such, reactive astrogliosis can be classified as
isomorphic (conserved morphology) or anisomorphic (astrocyte
hypertrophy and proliferation) (Verkhratsky et al., 2013). These
reactive states differ, not only in morphology, but also in their
(patho)physiological functions. For instance, isomorphic gliosis
is thought to aid regeneration of neuronal networks by providing
a permissive biochemical microenvironment for growth cones
to migrate through on their journey to relocate their correct
synaptic targets. On the other hand, anisomorphic astrogliosis
contributes to glial scar formation which is initially beneficial
because it prevents extensive neurodegeneration, but as the
primary trauma heals, the glial scar can also inhibit axonal
re-growth across the lesion site due to secretion of factors such as
chondroitin sulfate proteoglycans (Bradbury et al., 2002; Fawcett,
2006). Interestingly, we have shown that addition of chondroitin
sulfate to the Xenopus brain in vivo causes widespread softening
of brain tissue (Koser et al., 2016). Therefore, differences in the
secretome of phenotypically and functionally distinct types of
reactive astrocyte could, in theory, explain the dichotomy in
brain tissue stiffness observed in Alexander disease (Wang et al.,
2018) versus cortical glial scars caused by a traumatic stab injury
(Moeendarbary et al., 2017). In both cases, however, astrogliosis
will likely disrupt neuronal mechanobiological signaling and
may trigger either neurodegenerative or neuroprotective/pro-
regenerative mechanisms. An important area for future research
will involve characterizing the role of Piezo1 in neurons and
glial cells in the injured or degenerating brain. With this aim in
mind, Piezo1 channel opening reportedly regulates the Hippo
signaling pathway (Pathak et al., 2014), which controls cell
proliferation and apoptosis. Piezo1 knockdown also decreases
levels of the mechanoresponsive transcriptional coactivator, Yes-
associated protein (YAP), in neural stem cells (Pathak et al., 2014)
suggesting that Piezo1 activation triggers YAP transcriptional
activity. Notably, YAP is highly expressed by astrocytes and
deletion of the YAP gene induces astrogliosis (Huang et al.,
2016). In Alexander disease, astrocytes overexpress nuclear YAP,
potentially as a result of increased brain tissue stiffness (Wang
et al., 2018). Whether upregulation of YAP is detrimental to
astrocytes or induces a protective phenotype is not yet known.
YAP has some protective functions and can activate suppressor
of cytokine signaling (SOCS) gene expression and, therefore, can
prevent astrocyte reactivity by downregulating the JAK–STAT
inflammatory pathway (Huang et al., 2016). Taken together, the
upregulation of astrocytic Piezo1 that we see around amyloid
plaques in the hippocampus and cortex of TgF344-AD rats could,
on the one hand, contribute to AD-associated astrogliopathy
and neurodegeneration but, on the contrary, astrocytic Piezo1
may instead drive anti-inflammatory signaling cascades through
YAP-mediated suppression of cytokine signaling that work in
concert to reduce reactive astrogliosis and neuroinflammation in
the aging AD brain.
CONCLUSION
The data presented here suggests that mechanoresponsive
astrocytes surrounding stiff amyloid plaques in the AD brain
upregulate Piezo1 channels for, as yet, unknown reasons.
Moreover, peripheral infection, a common comorbidity in
elderly people with AD, augments Piezo1 channel expression in
astrocytes. This suggests a potential role for pro-inflammatory
microglia in regulating astrocytic Piezo1 levels. Future studies
will focus on the signaling cascades triggered by Piezo1-
mediated currents in reactive astrocytes and Piezo1 as a
potential therapeutic target for amyloid plaque-induced
neurodegeneration in AD.
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